Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire
| Autor: | Dominique Himbert, Nikolaos Bonaros, Cornelia Deutsch, Marina Urena-Alcazar, Martin Thoenes, Carlo Di Mario, Lukas Stastny, Jorge Salgado-Fernandez, Jana Kurucova, Pierluigi Stefàno, Bruno Garcia, Jose Joaquin Cuenca Castillo, Flavio Ribichini, Mauro Romano, Simon Kennon, Peter Bramlage, Thierry Lefèvre, Derk Frank, Rima Styra, Lenka Sykorova, Claudia M. Lüske |
|---|---|
| Přispěvatelé: | Institut Català de la Salut, [Kennon S] Department of Cardiology, Barts Heart Centre, St Bartholomew’s Hospital, London, UK. [Styra R] Department of Psychiatry, University Health Network, Toronto, Ontario, Canada. [Bonaros N, Stastny L] Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria. [Romano M] Department of Thoracic and Cardiovascular Surgery, Hopital Prive Jacques Cartier, Massy, France. [Lefèvre T] Institut Jacques Cartier, Massy, France. [Garcia B] Servei de Cardiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. CIBER CV, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT] Health Status medicine.medical_treatment aortic valve stenosis Aortic valve replacement Quality of life Valve replacement Surveys and Questionnaires Clinical endpoint Postoperative Period Prospective Studies Cardiovascular Diseases::Heart Diseases::Heart Valve Diseases::Aortic Valve Stenosis [DISEASES] ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida [ATENCIÓN DE SALUD] Aged 80 and over healthcare Other subheadings::Other subheadings::/surgery [Other subheadings] Europe quality of healthcare Aortic Valve Aortic valve stenosis Cohort Female aortic diseases heart valve prosthesis implantation outcome assessment Aged Aortic Valve Stenosis Canada Follow-Up Studies Humans Morbidity Transcatheter Aortic Valve Replacement Quality of Life Cardiology and Cardiovascular Medicine Qualitat de vida - Avaluació medicine.medical_specialty Qüestionaris Vàlvula aòrtica - Estenosi - Cirurgia medicine Diseases of the circulatory (Cardiovascular) system business.industry Otros calificadores::Otros calificadores::/cirugía [Otros calificadores] técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS] medicine.disease Surgery Stenosis Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life [HEALTH CARE] enfermedades cardiovasculares::enfermedades cardíacas::enfermedades de las válvulas cardíacas::estenosis de la válvula aórtica [ENFERMEDADES] RC666-701 Valvular Heart Disease Observational study business |
| Zdroj: | Scientia Open Heart Open Heart, Vol 8, Iss 2 (2021) |
| Popis: | BackgroundThe Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) is a validated instrument for assessing quality of life (QoL) in patients with severe aortic stenosis (AS). In this study, we evaluated health status outcomes, based on the TASQ, in patients with severe AS undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR).MethodsThe TASQ registry was a prospective observational registry. Patients with severe AS from nine centres in Europe and one in Canada underwent either SAVR or transfemoral TAVR. Patients completed the TASQ, Kansas City Cardiomyopathy Questionnaire and Short Form-12 V.2 prior to the intervention, predischarge, and at 30-day and 3-month follow-ups. Primary end point was the TASQ score.ResultsIn both the TAVR (n=137) and SAVR (n=137) cohorts, significant increases were observed in all three scores. The overall TASQ score improved as did all but one of the individual domains at 3 months after the intervention (pConclusionsThe TASQ captured changes in QoL among patients with severe AS who were treated with TAVR or SAVR. QoL improved substantially after either intervention, as indicated by changes in the TASQ overall score at 3 months.Trial registration numberNCT03186339. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|